Health & Environmental Research Online (HERO)


Print Feedback Export to File
2850216 
Journal Article 
Microminipigs as a new experimental animal model for toxicological studies: comparative pharmacokinetics of perfluoroalkyl acids 
Guruge, KS; Noguchi, M; Yoshioka, K; Yamazaki, E; Taniyasu, S; Yoshioka, M; Yamanaka, N; Ikezawa, M; Tanimura, N; Sato, M; Yamashita, N; Kawaguchi, H 
2015 
Yes 
Journal of Applied Toxicology
ISSN: 0260-437X
EISSN: 1099-1263 
WILEY 
HOBOKEN 
36 
68-75 
English 
In this study, we evaluated the efficacy of a novel minipig strain, the Microminipig (MMPig), as an animal model for studying the pharmacokinetics of a mixture of 10 perfluoroalkyl acids (PFAAs). After a single oral dose was given, we found that the blood depuration of PFAAs (blood t1/2 ), which we calculated using first-order elimination curves, ranged from 1.6 to 86.6 days. Among the five body compartments analyzed, the liver was the greatest site of accumulation of perfluorooctanesulfonate and longer chain perfluorinated carboxylates such as perfluorodecanoic acid, perfluoroundecanoic acid and perfluorododecanoic acid. We observed an increasing accumulation trend of perfluorinated carboxylates in the organs associated with the fluorinated carbon chain length. The perfluorononanoic acid burden was the highest among the treated compounds 21 days after a single exposure, as 29% of the given perfluorononanoic acid dose was accumulated in the tissues. The persistence of PFAAs in edible pig tissues even after 21 days post-exposure raises concerns about the safety of swine products. This was the first study to use MMPigs to elucidate the pharmacokinetics of a group of environmental pollutants. We found that MMPigs could be excellent experimental animals for toxicological studies due to their easy handling, cost efficacy for target compounds and ease of waste treatment. Copyright © 2015 John Wiley & Sons, Ltd. 
microminipig; experimental animal; pharmacokinetics; perfluoro compounds; biomedical studies 
PFAS
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
               WOS
     PFDoA (307-55-1)
          Literature Search
               Pubmed
               WOS
     PFUnA (2058-94-8)
          Literature Search
               Pubmed
               WOS
     PFDA (335-76-2)
          Literature Search
               Pubmed
               WOS
     PFNA (375-95-1)
          Literature Search
               Pubmed
               WOS
• PFBA
     Scopus: April 2021
• PFDA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               ADME
               Mixture only
     Scopus: April 2021
• PFDoA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
• PFHxS
• PFNA
     Literature Search (August 2017)
          Pubmed
     Litsearch Update 2017-2018
          Toxline
     Litsearch Addl Synonyms 2018
          WOS
     PFNA Literature Search pre-2019
          Pubmed
          WOS
     Literature Search
          Pubmed
          Toxline
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               ADME
               Mixture-only
     Scopus Lit Search April 2021
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
     Literature Search Update (2013-2019)
          PubMed
          WOS
• PFUnA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME